Summary
Bristol-Myers Squibb Company (BMY) filed an 8-K on January 25, 2007, reporting its financial results for the fourth quarter and full year of 2006. The filing primarily serves to furnish the press release detailing these results and related 2007 earnings guidance. While the 8-K itself does not contain the full financial details, it directs investors to Exhibit 99.1 (the press release) and Exhibit 99.2 (supplemental website information) for a comprehensive understanding of the company's performance and future outlook.
Key Highlights
- 1BMY filed an 8-K on January 25, 2007, to report financial results.
- 2The report covers the fourth quarter and twelve months of 2006.
- 3The filing includes the company's 2007 earnings guidance.
- 4Key financial results are detailed in an attached press release (Exhibit 99.1).
- 5Supplemental financial information is available on the BMY website (Exhibit 99.2).
- 6The 8-K formally discloses the financial reporting event as per SEC regulations.
Frequently Asked Questions
The primary purpose of this 8-K filing is to officially report Bristol-Myers Squibb Company's financial results for the fourth quarter and the full year of 2006. It also serves to provide the company's earnings guidance for 2007.
The detailed financial results for Q4 and full-year 2006, along with the 2007 earnings guidance, are primarily located in the press release furnished as Exhibit 99.1 to this 8-K. Additional supplemental information may also be found on the company's website at www.bms.com, as indicated in Exhibit 99.2.
This 8-K filing itself does not contain the specific financial figures. It directs investors to the attached press release (Exhibit 99.1) and supplemental website information (Exhibit 99.2) where the detailed financial results and earnings guidance are presented.